Abstract:The potential estrogenic activities of perfluoroalkyl substances (PFASs) are controversial. Here, we investigated the estrogenic/antiestrogenic activities of PFASs and explored the corresponding interaction mode of PFASs with the estrogen receptor (ER) by combining in vitro assays and in silico modeling. We found that three PFASs (perfluorobutanoic acid, perfluorobutane sulfonate, and perfluoropentanoic acid) exerted antiestrogenic effects by inhibiting luciferase activity, whereas perfluorohexane sulfonate (PFHxS) and perfluorooctane sulfonate (PFOS) exerted estrogenic effects by inducing luciferase activity. When coexposed to 17β-estradiol (E2), all tested PFASs attenuated the E2-stimulated luciferase activity; unexpectedly, each PFAS could further attenuate the luciferase activity generated by the cotreatment with ICI 182,780 and E2, with a minimal effective concentration comparable to that found in human serum. PFHxS and PFOS significantly induced the gene expression of TFF1; additionally, all PFASs inhibited the E2-induced gene expression of TFF1 and EGR3. Furthermore, the results of the blind docking analyses suggested that the interaction with the coactivator-binding region on the ER surface should be included as a pathway through which PFASs exert estrogenic and antiestrogenic activities. Finally, we revealed the critical molecular property of the zero-order molecular connectivity index (MCI) (0χ) that affects the antiestrogenic activity of PFASs.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.est.0c03468?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.est.0c03468</a>.Structures of tested chemicals (Table S1); concentrations of PFASs in exposure solutions (Table S2); binding free energy components of E2 and PFOS in the ER–E2–PFOS complex (Table S3); compounds, parameters, and activity data (Table S4); RNA isolation and reverse transcription polymerase chain reaction (RT-PCR) (part 1); in silico computational model (part 2); concentration–response luciferase activity of PFASs that gave a minor response in the MVLN assay (Figure S1); ERE-luciferase assay of PFASs in MVLN cells after cotreatment with E2 and ICI 182,780 (Figure S2); binding modes of 10 PFASs molecules in HIP molecular modeling (Figure S3); binding modes of 10 PFASs molecules in HIE molecular modeling (Figure S4); RMSD changes in MD simulations (Figure S5); and empirical distribution of R2* for the pEC50 model (Figure S6) (<a class="ext-link" href="/doi/suppl/10.1021/acs.est.0c03468/suppl_file/es0c03468_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Binding Specificities of Estrogen Receptor with Perfluorinated Compounds: A Cross Species Comparison.

Perfluorinated compounds binding to estrogen receptor of different species: a molecular dynamic modeling

Molecular Modeling and Molecular Dynamics Simulation Studies on the Interactions of Hydroxylated Polychlorinated Biphenyls with Estrogen Receptor-β

Molecular Docking, Molecular Dynamics Simulation, and Structure-Based 3D-QSAR Studies on the Aryl Hydrocarbon Receptor Agonistic Activity of Hydroxylated Polychlorinated Biphenyls.

Structure-dependent binding and activation of perfluorinated compounds on human peroxisome proliferator-activated receptor γ

The Endocrine Disrupting Effect of Perfluorooctanoic Acid (pfoa) on Human Estrogen, Androgen and Thyroid Receptors

Analysis of Binding Modes between Three Perfluorosulfonates and GPER Based on Computational Simulation and Multiple Spectral Methods

Evaluation of the Estrogenic/Antiestrogenic Activities of Perfluoroalkyl Substances and Their Interactions with the Human Estrogen Receptor by Combining In Vitro Assays and In Silico Modeling

Protonation state effects of estrogen receptor α on the recognition mechanisms by perfluorooctanoic acid and perfluorooctane sulfonate: A computational study.

Perfluorooctane sulfonate-induced testicular toxicity and differential testicular expression of estrogen receptor in male mice.

Assessment of Endocrine-Disrupting Effects of Emerging Polyhalogenated Carbazoles (phczs): in Vitro, in Silico, and in Vivo Evidence

Potential Estrogenic Effects Of Phosphorus-Containing Flame Retardants

Poly- and perfluorinated compounds activate human pregnane X receptor

Integration of in silico approaches to determination of endocrine-disrupting perfluorinated chemicals binding potency with steroidogenic acute regulatory protein

Quantitative Characterization of Short- and Long-Chain Perfluorinated Acids in Solid Matrices in Shanghai, China

Exploring toxicity of perfluorinated compounds through complex network and pathway modeling

Tissue distribution of emerging per- and polyfluoroalkyl substances in wild fish species from Qiantang river, east China: Comparison of 6:2 Cl-PFESA with PFOS

Molecular Docking and Molecular Dynamics Studies on the Interactions of Hydroxylated Polybrominated Diphenyl Ethers to Estrogen Receptor Alpha.

Perfluorinated iodine alkanes promote the differentiation of mouse embryonic stem cells by regulating estrogen receptor signaling

Estrogen-Like Properties of Perfluorooctanoic Acid As Revealed by Expressing Hepatic Estrogen-Responsive Genes in Rare Minnows (gobiocypris Rarus)

Analyzing the impact of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) on the reproductive system using network toxicology and molecular docking